---
figid: PMC9359433__fonc-12-932353-g002
figtitle: RET signaling pathway and RET inhibitors in human cancer
organisms:
- Homo sapiens
- Mus musculus
- Drosophila melanogaster
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
- Mus musculus
pmcid: PMC9359433
filename: fonc-12-932353-g002.jpg
figlink: /pmc/articles/PMC9359433/figure/f2/
number: F2
caption: Altered RET and their mechanisms of activation. (A) Schematic representation
  of the fusion between the tyrosine kinase domain of wild-type (WT) RET receptor,
  and the kinesin and coiled-coil (CC) domain of a fusion partner. Dashed lines represent
  fusion sites. (B) Cysteine mutations in RET cysteine-rich domain (CRD) promote formation
  of intermolecular disulfide bridges, leading to constitutive dimerization and activation
  of RET that is GDNF-independent. Mutations in RET tyrosine kinase domains (TKD)
  can elicit steric conformations that regulate access to the ATP binding pocket of
  RET (E768X, V804X), alter hinge or inter-lobe flexibility (L790X, Y791X), promote
  activation of RET monomers (S891X, M918T), or destabilize the inactive form of RET
  (A883X), all of which confer constitutive RET activation albeit with varying activities.
  (C) Activation of either WT RET or oncogenic RET fusions can promote activation
  of downstream pathways, PI3K/AKT, RAS/RAF/MEK/ERK, JAK2/STAT3, and PLCγ resulting
  in enhanced proliferation, migration, cell survival and differentiation, ultimately
  promoting neoplastic growth and tumorigenesis.
papertitle: RET signaling pathway and RET inhibitors in human cancer.
reftext: Angelina T. Regua, et al. Front Oncol. 2022;12:932353.
year: '2022'
doi: 10.3389/fonc.2022.932353
journal_title: Frontiers in Oncology
journal_nlm_ta: Front Oncol
publisher_name: Frontiers Media S.A.
keywords: RET | cancer | therapeutics | lung cancer | thyroid cancer
automl_pathway: 0.8041645
figid_alias: PMC9359433__F2
figtype: Figure
redirect_from: /figures/PMC9359433__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9359433__fonc-12-932353-g002.html
  '@type': Dataset
  description: Altered RET and their mechanisms of activation. (A) Schematic representation
    of the fusion between the tyrosine kinase domain of wild-type (WT) RET receptor,
    and the kinesin and coiled-coil (CC) domain of a fusion partner. Dashed lines
    represent fusion sites. (B) Cysteine mutations in RET cysteine-rich domain (CRD)
    promote formation of intermolecular disulfide bridges, leading to constitutive
    dimerization and activation of RET that is GDNF-independent. Mutations in RET
    tyrosine kinase domains (TKD) can elicit steric conformations that regulate access
    to the ATP binding pocket of RET (E768X, V804X), alter hinge or inter-lobe flexibility
    (L790X, Y791X), promote activation of RET monomers (S891X, M918T), or destabilize
    the inactive form of RET (A883X), all of which confer constitutive RET activation
    albeit with varying activities. (C) Activation of either WT RET or oncogenic RET
    fusions can promote activation of downstream pathways, PI3K/AKT, RAS/RAF/MEK/ERK,
    JAK2/STAT3, and PLCγ resulting in enhanced proliferation, migration, cell survival
    and differentiation, ultimately promoting neoplastic growth and tumorigenesis.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - slmb
  - tkd
  - cld
  - Rca1
  - Cenp-C
  - CycA
  - cal1
  - Khc
  - Klc
  - Ret
  - reticulated
  - reti
  - rets
  - lmd
  - Akt
  - Dsor1
  - Mtk
  - Raf
  - Erk7
  - rl
  - sl
  - ATPsynbeta
  - Atpalpha
  - form3
  - CRX
  - RPGR
  - TTN
  - SLC26A3
  - CLDN1
  - CXCR1
  - CENPE
  - KIF11
  - KIF12
  - KIF13A
  - KIF13B
  - KIF14
  - KIF15
  - KIF16B
  - KIF17
  - KIF18A
  - KIF18B
  - KIF19
  - KIF1A
  - KIF1B
  - KIF1C
  - KIF20A
  - KIF20B
  - KIF21A
  - KIF21B
  - KIF22
  - KIF23
  - KIF24
  - KIF25
  - KIF26A
  - KIF26B
  - KIF27
  - KIF2A
  - KIF2B
  - KIF2C
  - KIF3A
  - KIF3B
  - KIF3C
  - KIF4A
  - KIF4B
  - KIF5A
  - KIF5B
  - KIF5C
  - KIF6
  - KIF7
  - KIF9
  - KIFC1
  - KIFC2
  - KIFC3
  - STARD9
  - RET
  - AKT1
  - AKT2
  - AKT3
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - EPHB2
  - MAPK1
  - MAPK3
  - STAT3
  - JAK2
  - PLCG1
  - PLCG2
  - ATP8A2
  - UBA2
  - Lmf1
  - Ccr8
  - Akt1
  - Mdk
  - Zhx2
  - Ephb2
  - Mapk1
  - Stat3
  - Jak2
---
